LeadIQ logo
Learn more at LeadIQ.com

Insights

Non-invasive CGM Opportunity to target outpatient diabetes management, fitness and lifestyle wearables, and hospital settings with Echo Therapeutics' non-invasive, wireless transdermal CGM system.

Platform SkinPrep Leverage the needle-free SkinPrep platform to enable transdermal drug delivery and enhanced analyte extraction, creating cross-sell potential with pharmaceutical partners and dermatology offerings.

Early Stage Funding With current revenue streams and a $45M funding backdrop, pursue strategic partnerships, licensing, or co-development deals to accelerate commercialization and validate the technology.

Targeted Partnerships Identify synergies with diabetes care players, bio-sensor integrators, and wearable-health brands to accelerate market entry and expand distribution beyond core niche.

Competitive Gaps Position against small peers and incumbents by emphasizing non-invasive advantage, potential hospital adoption, and the SkinPrep platform as a differentiator to win pilot programs and early adopters.

Similar companies to Echo Therapeutics

Echo Therapeutics Tech Stack

Echo Therapeutics uses 4 technology products and services including Google Fonts API, Twemoji, Yoast SEO, and more. Explore Echo Therapeutics's tech stack below.

  • Google Fonts API
    Font Scripts
  • Twemoji
    Font Scripts
  • Yoast SEO
    Search Engines
  • Apache
    Web Servers

Echo Therapeutics's Email Address Formats

Echo Therapeutics uses at least 1 email format:
Echo Therapeutics Email FormatsExamplePercentage
FLast@echotx.comJDoe@echotx.com
100%

Frequently Asked Questions

What is Echo Therapeutics's phone number?

Minus sign iconPlus sign icon You can contact Echo Therapeutics's main corporate office by phone at
+1-215-717-****
. For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Echo Therapeutics's stock symbol?

Minus sign iconPlus sign iconEcho Therapeutics is a publicly traded company; the company's stock symbol is ECTE.

What is Echo Therapeutics's official website and social media links?

Minus sign iconPlus sign iconEcho Therapeutics's official website is echotx.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Echo Therapeutics generate?

Minus sign iconPlus sign icon As of September 2026, Echo Therapeutics's annual revenue is estimated to be $1M - $10M.

What is Echo Therapeutics's NAICS code?

Minus sign iconPlus sign iconEcho Therapeutics's NAICS code is 3391 - Medical Equipment and Supplies Manufacturing.

How many employees does Echo Therapeutics have currently?

Minus sign iconPlus sign iconAs of September 2026, Echo Therapeutics has approximately 8 employees across 3 continents, including North America, Europe and Asia. Key team members include Chairman And Chief Executive Officer: P. M. and Principal: S. U. Explore Echo Therapeutics's employee directory with LeadIQ.

What industry does Echo Therapeutics belong to?

Minus sign iconPlus sign iconEcho Therapeutics operates in the Medical Equipment Manufacturing industry.

What technology does Echo Therapeutics use?

Minus sign iconPlus sign iconEcho Therapeutics's tech stack includes Google Fonts API, Twemoji, Yoast SEO and Apache.

What is Echo Therapeutics's email format?

Minus sign iconPlus sign iconEcho Therapeutics's email format typically follows the pattern of FLast@echotx.com. Find more Echo Therapeutics email formats with LeadIQ.

How much funding has Echo Therapeutics raised to date?

Minus sign iconPlus sign icon As of September 2026, Echo Therapeutics has raised $45M in funding. The last funding round occurred on Feb 08, 2016 for $1.8M.
Echo Therapeutics logo

Echo Therapeutics

Medical Equipment ManufacturingNew Jersey, United States2-10 Employees

Echo Therapeutics is a medical equipment manufacturer based in Iselin, New Jersey. The company is developing a non-invasive, wireless continuous glucose monitoring system that aims to provide real-time glucose data without needles. It has also created a needle-free skin preparation device that facilitates sampling of analytes such as glucose and can enhance the delivery of topical medications. The company identifies opportunities in outpatient diabetes management and in wearable-health applications focused on fitness and weight management, with longer-term potential in hospital settings. The organization is small, reflecting a focused development profile within the medical equipment sector.

Section iconCompany Overview

Phone number
+1-215-717-****
Website
echotx.com
Stock Symbol
ECTE
NAICS Code
3391 - Medical Equipment and Supplies Manufacturing
Employees
2-10

Section iconMedia & News

Section iconFunding & Financials

  • $45M

    Echo Therapeutics has raised a total of $45M of funding over 10 rounds. Their latest funding round was raised on Feb 08, 2016 in the amount of $1.8M as a Post IPO Debt.

  • $1M - $10M

    Echo Therapeutics's revenue is estimated to be in the range of $1M - $10M

Company Leadership

  • Chairman And Chief Executive Officer at Echo Therapeutics
    P. M.
    Chairman And Chief Executive Officer
    Mobile Phone
  • Principal at Echo Therapeutics
    S. U.
    Principal
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.